 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
Bioassay and Drug Development Group |
| |
Since TCM has demonstrated its effectiveness in the treatment of ailments and diseases over its long history of empirical use, they are very likely to possess natural products of potential therapeutic value. BRI is utilizing this wealth of empirical experience and the vast variety of TCMs to conduct a knowledge-based drug discovery effort. Biological assays are being utilized to screen TCM products and botanicals for therapeutically active compounds. |
| Current Studies | ||
 |
Evaluate the efficacy of TCM products | |
|
Investigate and understand the underlying mechanisms of actions governing TCM products | |
|
Identify TCM products with therapeutic potentials | |
|
Identify active fractions for development | |
|
Discover lead compounds for new drug development | |
|
|
||
| Focused Therapeutic Areas | ||
|
Neurodegenerative diseases, such as: | |
| Alzheimer's Disease | ||
| Parkinsons's Disease | ||
| Amyotrophic Lateral Sclerosis | ||
|
Pain and drug addiction | |
|
Stroke | |
|
Epilepsy | |
|
Cancer | |
|
Hormone regulation | |
|
Immunomodulation | |
|
Anti-ageing | |
[ Bioassay and Drug Development ] [ Safety and Standardization ] [ Reformulation and Pharmaceutics ]
 |